STAQ Pharma recalls 500mL ROPivacaine HCl 0.2% injection bags with leaking issues. These bags were manufactured by a third party and failed quality checks. Consumers should check lot numbers on the packaging.
STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was with the bag manufacturer who released bags Lot # 134142-001A which had failed internal QC tests for leaks.
Take action
Contact the company
📍Recalling firmSTAQ Pharma, Inc.14135 E 42nd Ave Ste 50 · Denver, CO 80239-5214
✎ GovInfoNow plain-language explainer
STAQ Pharma is recalling 500mL ROPivacaine HCl 0.2% injection bags that may leak. The leak risk comes from bags produced by a third-party manufacturer that failed internal quality tests. This could lead to contamination or improper medication delivery if the bag leaks during use. Read more at govinfonow.com/recall/32935-staq-pharma-ropivacaine-hcl-0-2-injection-recall-leaking-bags.
“STAQ Pharma ROPivacaine HCl 0.2% Injection Recall: Leaking Bags Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32935-staq-pharma-ropivacaine-hcl-0-2-injection-recall-leaking-bags. Based on FDA recall #D-0147-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0147-2024%22&limit=1).
The FDA announced on 2023-11-29 that STAQ Pharma, Inc. is recalling ROPivacaine HCl Injection bags due to leaking containers. The recall involves 2,616 units distributed nationwide.
How to tell if you have it
Brand: STAQ Pharma
Product: ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags
STAQ Pharma received consumer complaints regarding leaking bags and other potential bag concerns. The company determined the issue originated from bag manufacturer Lot # 134142-001A, which failed internal quality control tests for leaks.
Context
GovInfoNow's records show STAQ Pharma, Inc. has two other recalls on record since 2022-02-03. On 2025-10-09, the company issued a recall for Ketamine Injection due to missing lot and expiration dates. On 2022-02-03, STAQ Pharma recalled Hydro morphine syringes with incorrect labeling. Other recent recalls of similar products include Baxter Dextrose 2000mL Bags Recall (2026-08-17), B Braun Dextrose Injection Recall (2026-04-02), and Keystone Pearson Topical Anesthetic Gel Recall (2026-05-21).
How to tell if you have this one
Check the lot number on the bag, which is listed as 23109472A through 23109522A. The product is a 500mL injection bag labeled for prescription use only, with specific expiration dates.
Brand
STAQ Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Bag Lot Number
Look for the lot number on the bag, which should be one of 23109472A through 23109522A.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0147-2024 (November 29, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0147-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.